DK1496884T3 - Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme - Google Patents

Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme

Info

Publication number
DK1496884T3
DK1496884T3 DK03745819T DK03745819T DK1496884T3 DK 1496884 T3 DK1496884 T3 DK 1496884T3 DK 03745819 T DK03745819 T DK 03745819T DK 03745819 T DK03745819 T DK 03745819T DK 1496884 T3 DK1496884 T3 DK 1496884T3
Authority
DK
Denmark
Prior art keywords
aspirin
mixture
treatment
antithrombotic agent
atherothrombotic diseases
Prior art date
Application number
DK03745819T
Other languages
English (en)
Inventor
Gilbert Lavielle
Bernard Cimetiere
Tony Verbeuren
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1496884T3 publication Critical patent/DK1496884T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03745819T 2002-04-05 2003-04-04 Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme DK1496884T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
DK1496884T3 true DK1496884T3 (da) 2006-10-02

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03745819T DK1496884T3 (da) 2002-04-05 2003-04-04 Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme

Country Status (27)

Country Link
US (1) US7618955B2 (da)
EP (1) EP1496884B1 (da)
JP (1) JP4065853B2 (da)
KR (1) KR100645143B1 (da)
CN (1) CN1297265C (da)
AR (1) AR039253A1 (da)
AT (1) ATE329591T1 (da)
AU (1) AU2003246774B2 (da)
BR (1) BR0309019A (da)
CA (1) CA2480697A1 (da)
CY (1) CY1105106T1 (da)
DE (1) DE60306133T2 (da)
DK (1) DK1496884T3 (da)
EA (1) EA006978B1 (da)
ES (1) ES2264533T3 (da)
FR (1) FR2838057B1 (da)
GE (1) GEP20074101B (da)
HK (1) HK1076034A1 (da)
MA (1) MA27114A1 (da)
MX (1) MXPA04009760A (da)
NO (1) NO20044700L (da)
NZ (1) NZ535430A (da)
PL (1) PL371620A1 (da)
PT (1) PT1496884E (da)
UA (1) UA79457C2 (da)
WO (1) WO2003084525A1 (da)
ZA (1) ZA200407593B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007010498A2 (en) * 2005-07-22 2007-01-25 The Procter & Gamble Company Compositions for reducing the incidence of drug induced arrhythmia
KR101473207B1 (ko) * 2007-04-13 2014-12-16 밀레니엄 파머슈티컬스 인코퍼레이티드 Ｘａ 인자 억제제로서 작용하는 화합물과의 병용 항응고 요법
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DE60306133D1 (de) 2006-07-27
BR0309019A (pt) 2005-02-01
KR100645143B1 (ko) 2006-11-10
HK1076034A1 (en) 2006-01-06
ZA200407593B (en) 2006-07-26
PL371620A1 (en) 2005-06-27
EA006978B1 (ru) 2006-06-30
CY1105106T1 (el) 2009-11-04
FR2838057A1 (fr) 2003-10-10
AU2003246774B2 (en) 2007-02-15
PT1496884E (pt) 2006-09-29
WO2003084525A1 (fr) 2003-10-16
JP2005528376A (ja) 2005-09-22
MXPA04009760A (es) 2004-12-13
NZ535430A (en) 2006-09-29
US20050143354A1 (en) 2005-06-30
KR20040098053A (ko) 2004-11-18
EP1496884A1 (fr) 2005-01-19
AR039253A1 (es) 2005-02-16
AU2003246774A1 (en) 2003-10-20
GEP20074101B (en) 2007-05-10
NO20044700L (no) 2004-10-29
MA27114A1 (fr) 2004-12-20
ATE329591T1 (de) 2006-07-15
CN1297265C (zh) 2007-01-31
US7618955B2 (en) 2009-11-17
DE60306133T2 (de) 2007-01-04
CA2480697A1 (fr) 2003-10-16
JP4065853B2 (ja) 2008-03-26
EP1496884B1 (fr) 2006-06-14
ES2264533T3 (es) 2007-01-01
EA200401293A1 (ru) 2005-02-24
FR2838057B1 (fr) 2005-07-08
UA79457C2 (en) 2007-06-25
CN1646111A (zh) 2005-07-27

Similar Documents

Publication Publication Date Title
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
IS7699A (is) Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
DK1765322T3 (da) Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser
DK1487541T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
DK1626728T3 (da) Oxiderede lipider og anvendelse heraf ved behandling af inflammatoriske sygdomme og forstyrrelser
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
IS8123A (is) Ný heteróhringlaga efnasambönd sem eru gagnleg í meðhöndlun á bólgu- og ofnæmissjúkdómum; aðferðir til að framleiða þau og lyfjablöndur sem innihaldaþau
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
IS8134A (is) Píperasínafleiður og notkun þeirra til að meðhöndla tauga- og geðsjúkdóma
IS8451A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS8410A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS7811A (is) Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum
IS8497A (is) Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma
DK1848415T3 (da) Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
DK1638589T3 (da) Kombinationsterapi med glatirameracetat og mitoxantron til behandling af multipel sklerose
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
DK1919290T3 (da) Fremgangsmåder og produkter til behandling af sygdomme
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1487418T3 (da) Lille CO-perle af DHA og rosmarin samt fremgangsmåder til anvendelse
IS6033A (is) Tálmar við amínótransferasa, sem háðir eru amínósýru með greinóttum keðjum, og notkun þeirra til meðhöndlunar á sjónusjúkdómum af völdum sykursýki
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi
IS7962A (is) Þíenópýridasínón og notkun þeirra í breytingu á sjálfsnæmissjúkdómi